BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help

Search Results

Documents 1-15 out of 15 found
  Current Search:  von: 159, disease: 8791, neurofibromatosis: 9     

HTML
50%
Bio/Data Corporation Launches vW Select - The World's First and Only Complete Ristocetin CoFactor Assay
HORSHAM, Pa., June 30 /PRNewswire/ -- Today, Bio/Data Corporation announced the launch of vW Select(TM), the world's first all-in-one Ristocetin CoFactor Assay.

vW Select is the first and only complete assay that measures the functional...

Pharma Live:  Jul 3 2009 11:38PM
Matching: von disease
Find similar documents
HTML
50%
Number Of Abortion Procedures Continues To Decline In Minnesota And Wisconsin
Number Of Procedures Continues To Decline In Minnesota And Wisconsin ~ Minnesota: The number of abortions performed in Minnesota decreased for the second Medical Medical Medical Worldwide Search / Oncology hip Funny Useful Websites details...
MediLexicon:  Jul 4 2009 7:59AM
Matching: von disease
Find similar documents
HTML
50%
Augmentation Index Relates to Progression of Aortic Disease in Adults With Marfan Syndrome
1Centre of Cardiology and Cardiovascular Surgery, University Hospital Eppendorf, Hamburg, Germany 2Department of Cardiology, Medical Clinic and Policlinic, University of Wurzburg, Wurzburg, Germany 3Department of Diagnostic and...
American Journal of Hypertension:  Jul 2 2009 8:13PM
Matching: von disease
Find similar documents
HTML
50%
Bio/Data Corporation Launches vW Select(TM) - The World's First and Only Complete Ristocetin CoFactor Assay
vW Select Significantly Reduces Laboratory Variability and Provides Clinicians with More Reliable Test Results HORSHAM, Pa., June 30 /PRNewswire/ -- Today, Bio/Data Corporation announced the launch of vW Select(TM), the world's first all-in...
KSLA:  Jun 30 2009 3:46PM
Matching: von disease
Find similar documents
HTML
50%
Bio/Data Corporation Launches vW Select(TM) - The World's First and Only Complete Ristocetin CoFactor Assay
vW Select Significantly Reduces Laboratory Variability and Provides Clinicians with More Reliable Test Results HORSHAM, Pa., June 30 /PRNewswire/ -- Today, Bio/Data Corporation announced the launch of vW Select(TM), the world's first all-in...
Montana's News Station:  Jun 30 2009 2:12PM
Matching: von disease
Find similar documents
HTML
50%
The Disappearing Flu Vaccine
In Maine patients phoning their doctors' offices to ask about flu shots are finding out there are none but are told they might check with local supermarkets and car dealerships.

The story has been going around that these establishments...

The Nation:  Jun 25 2009 11:26PM
Matching: von disease
Find similar documents
HTML
50%
International Panel Of Experts Reaches Consensus On Diagnosis And Treatment Of Bleeding Disorders In Women
Because bleeding from the reproductive tract is a naturally occurring event during menstruation and childbirth, women who exhibit menorrhagia, or excessive bleeding after their menstrual cycle, may have underlying diseases that are...
Medical News Today:  Jun 4 2009 2:36PM
Matching: von disease
Find similar documents
HTML
50%
Experts reach consensus on diagnosis and treatment of bleeding disorders in women
Because bleeding from the reproductive tract is a naturally occurring event during menstruation and childbirth, women who exhibit menorrhagia, or excessive bleeding after their menstrual cycle, may have underlying diseases that are...
Genetic Engineering News:  Jun 3 2009 8:27AM
Matching: von disease
Find similar documents
HTML
50%
New Guidelines To Help Diagnose Bleeding Disorders
Nearly one percent of the population suffers from bleeding disorders, yet many women don't know they have one because doctors aren't looking for the condition, according to researchers at Duke University Medical Center.

That's about to...

Medical News Today:  Jun 3 2009 4:14PM
Matching: von disease
Find similar documents
HTML
50%
Bleeding disorders going undiagnosed; new guidelines to help
DURHAM, NC -- Nearly one percent of the population suffers from bleeding disorders, yet many women don't know they have one because doctors aren't looking for the condition, according to researchers at.

That's about to change, now that an...

Genetic Engineering News:  Jun 2 2009 4:48AM
Matching: von disease
Find similar documents
HTML
50%
Bleeding disorders going undiagnosed
Nearly one percent of the population suffers from bleeding disorders, yet many women don't know they have one because doctors aren't looking for the condition, according to researchers at Duke University Medical Center.

That's about to...

Scientist Live:  Jun 2 2009 4:56PM
Matching: von disease
Find similar documents
HTML
50%
Bleeding disorders going undiagnosed; new guidelines to help
DURHAM, NC -- Nearly one percent of the population suffers from bleeding disorders, yet many women don't know they have one because doctors aren't looking for the condition, according to researchers at Duke University Medical Center.

That...

Genetic Engineering News:  Jun 2 2009 9:59AM
Matching: von disease
Find similar documents
HTML
50%
Bleeding disorders going undiagnosed; new guidelines to help
Nearly one percent of the population suffers from bleeding disorders, yet many women don't know they have one because doctors aren't looking for the condition, according to researchers at Duke University Medical Center.

That's about to...

News-Medical.Net:  Jun 2 2009 8:39AM
Matching: von disease
Find similar documents
HTML
50%
Subgruppen-Daten aus zwei randomisierten Studien in Phase 3 zeigen, dass TYSABRI die gesundheitsbezogene Lebe
Die Elan Corporation, plc (NYSE: ELN) und Biogen Idec (NASDAQ: BIIB): Subgruppen-Daten aus zwei randomisierten Studien in Phase 3 zeigen, dass TYSABRI die gesundheitsbezogene Lebensqualitt von Morbus-Crohn-Patienten deutlich erhht, die...
FinanzNachrichten.de:  Jun 1 2009 4:57PM
Matching: von disease
Find similar documents
HTML
50%
Intercell starts a Phase I clinical trial for a new Streptococcus pneumoniae vaccine
Initiation of a first?in?man Phase I clinical trial in healthy subjects Study aims to obtain safety and immunogenicity data of this new vaccine candidate Initial results expected in Q4 2009 Development of Intercells Streptococcus pneumoniae...
Pharma Live:  Apr 7 2009 1:24PM
Matching: von disease
Find similar documents


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.